Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 19;20(3):e0316884.
doi: 10.1371/journal.pone.0316884. eCollection 2025.

Unveiling the Drivers of Polio Vaccine Uptake: Insights from a Multi-Country Study of 37 Nations in Sub-Saharan Africa

Getayeneh Antehunegn Tesema  1 , Michael Sarfo  2 , Sylvester R Okeke  3 , Edward Kwabena Ameyaw  4   5 , Sanni Yaya  6
Affiliations

Unveiling the Drivers of Polio Vaccine Uptake: Insights from a Multi-Country Study of 37 Nations in Sub-Saharan Africa

Getayeneh Antehunegn Tesema et al. PLoS One. .

Abstract

Background: Childhood vaccination is a highly cost-effective strategy for preventing vaccine-preventable diseases, including poliomyelitis. Despite advancements in vaccination coverage across Africa, polio remains a public health concern. Limited multi-country analyses on oral polio vaccine (OPV) dropout in African nations hinder the development of context-specific interventions. This study investigates OPV uptake and associated factors in sub-Saharan Africa (SSA).

Methods: This study analyzed data from the Demographic and Health Surveys of 37 sub-Saharan African countries, encompassing 60,846 children aged 12-23 months. Multilevel multinomial logistic regression models were employed to explore associations between individual- and community-level factors and vaccination status, categorized as non-vaccinated, dropout, or fully vaccinated. Four nested models were assessed, with the model exhibiting the lowest deviance (-2 Log-likelihood Ratio (-2LLR)) identified as the best fit. Variables with p-values < 0.2 in bivariable analysis were included in the multivariable analysis. The adjusted Relative Risk Ratios (aRRR) with 95% Confidence Intervals (CI) were reported to determine statistical significance and the strength of associations.

Results: Among children aged 12-23 months, OPV1, OPV2, and OPV3 coverage rates were 86.59%, 81.27%, and 68.41%, respectively. The prevalence of OPV dropout and full vaccination in SSA were 19.38% (95% CI: 19.06%, 19.69%) and 67.77% (95% CI: 67.40%, 68.14%), respectively, with a dropout rate of 20.98%. Key factors significantly associated with non-vaccination included maternal education (primary: aRRR = 0.58; secondary: aRRR = 0.64; higher: aRRR = 0.75), household wealth (poorer: aRRR = 0.91; middle: aRRR = 0.82; richer: aRRR = 0.70), maternal age (20-29: aRRR = 0.67; 30-39: aRRR = 0.60; 40-49: aRRR = 0.59), health facility delivery (aRRR = 0.28), media exposure (aRRR = 0.64), marital status (currently married: aRRR = 0.87), parity (2-3 births: aRRR = 1.11), and rural residence (aRRR = 0.73). Regional disparities revealed higher risks of non-vaccination and dropout in Southern, Central, and West Africa compared to East Africa.

Conclusion: This study highlights the multifaceted determinants of oral polio vaccination dropout in SSA. Targeted interventions, such as improving maternal education, enhancing access to healthcare facilities, addressing socioeconomic inequalities, and mitigating regional disparities, are essential to boosting vaccination coverage and preventing polio resurgence. Focused efforts in Western and Central Africa are critical to sustaining and expanding vaccination programs.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. The prevalence of dropout and full vaccination of polio among children aged 12-23 months in included countries in sub-Saharan Africa.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Ozawa S, Clark S, Portnoy A. Return on investment from childhood immunization in low- and middle-income countries, 2011-20. Health Affairs. 2016. - PubMed
    1. Centers for Disease Control and Prevention. Benefits from immunization during the vaccines for children program era United States, 1994–2013. MMWR. 2014;63(1):1–10. doi: 10.XXXX/XXXX - DOI - PMC - PubMed
    1. Brickley EB, Wieland-Alter W, Connor RI, Ackerman ME, Boesch AW, Arita M, et al.. Intestinal immunity to poliovirus following sequential trivalent inactivated polio vaccine/bivalent oral polio vaccine and trivalent inactivated polio vaccine-only immunization schedules: analysis of an open-label, randomized, controlled trial in chilean infants. Clin Infect Dis. 2018;67(suppl_1):S42–50. doi: 10.1093/cid/ciy603 - DOI - PMC - PubMed
    1. Xiao Y, Daniell H. Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines. Vaccine. 2017;35(40):5418–25. doi: 10.1016/j.vaccine.2016.12.061 - DOI - PMC - PubMed
    1. Guerra S, Roope LS, Tsiachristas A. Assessing the relationship between coverage of essential health services and poverty levels in low- and middle-income countries. Health Policy Plan. 2024;39(2):156–67. doi: 10.1093/heapol/czae002 - DOI - PMC - PubMed

Substances